v3.26.1
Organization, Business Operations and Liquidity (Details Narrative) - USD ($)
Jul. 11, 2026
Mar. 31, 2026
Dec. 01, 2025
Organization Consolidation And Presentation Of Financial Statements [Line Items]      
Goodwill   $ 0  
Transaction Agreement [Member] | Forecast [Member]      
Organization Consolidation And Presentation Of Financial Statements [Line Items]      
Termination fee $ 2,500,000    
Reimburse expensess $ 1,000,000    
Asset Purchase Agreement [Member]      
Organization Consolidation And Presentation Of Financial Statements [Line Items]      
cash transactions   1,325,000  
deferred purchase price   1,000,000  
Services fees expense   $ 175,000  
Rorschach Cayman LLC [Member]      
Organization Consolidation And Presentation Of Financial Statements [Line Items]      
Ownership percentage     100.00%
Guidant Bio Therapeutics Inc. [Member] | Asset Purchase Agreement [Member]      
Organization Consolidation And Presentation Of Financial Statements [Line Items]      
percentage of common stock interest   40.00%